46
1 1 50.1 2 34 kgkg100 XCT100cm 2 2005 1100cm 2 85 cm90 cm 5 5 1 2 6OSCE OSCE 7 8 9 13 14 16 17 17 20 18 19 22 23 25 19 26
6 BMI 4.0g/ml 6 2 7 RIA EIA 8 3.10.3 ng/ml 7.91.2 ng/ml 2 7401620 2002 9 11 2 c c d d d c c 7 9
11 9 140mg/dl126mg/dl 3110mg/dl75g 140mg/dl 10 9 3 11 20025 LDL- 6 6 12 10 2002 1,5-1,5-AG C- 75gOral Glucose Tolerance Test, OGTT75g60 120 GADglutamic acid decarboxylasegad 4 10 HDL LDL- HDL LDL-A-A- BC-C-ERLPremnant like particle LPa remnant-like lipoprotein choresterol 12 E C VLDL
2.20.1mg/dl 4 89 1 510 mmhg 2002 11 WHOISH 140/90mmHg 3120/80mmHg 130/85mmHg130139/8589 mmhg 100mmHg 140159mmHg 180mmHg7 14 7 5 1980MayoLudwing 1998 10NASH 53050NASH nonalcholic fatty liver disease; NAFLDNASH NASHNAFLD1 15 CE 1992 1 NASH45 14 DRG/PPSDiagnosis-Related Group/Prospective Payment System
16 20g/ 15g/ ASTALT ASTBMI 30 45 n kg/m 2 117 1024.000 18 3 17 BMI 25Kg/m 2 BMI 18.521.9 Kg/m 2 1 1.403.242.13 1.83 1 544174232004 2http://www2.ttcn.ne.jp/~honkawa/2240.html 3 84517-5212002 4http://web-doctors.jp/sheets/002.html 5http://zyloric.jp/metabolic/cont02/index.html 6 24125-34, 2005 7 241 35-39 2005 8 34111152-11532006 95- - 72-86 2004 10DRG/PPS2002 424. 103107145 114 -- 58-71 2004 12DRG/PPS2002 425. 108111145 13RLP 34111142-11452006 14DRG/PPS2002 426.108111145 15 2005 165012-13 2006 17van Dam RM et al: The relationship between overweight in adolescence and premature dealth in women 2006; 145 91-97 Ann Interm Med. 38 42 53 12 13 16183 18 18 514 21029
19 12 3 4 CBTComputer-based Testing OSCEObjective Structured Clinical Examination 622 56 25 2 1843 182504142740 19421 18121342 10019422 204 191216 4 6
SPstandardized patients OSCE161100 1 48 9622 OB OSCE 192OSCE 19422 201OSCE 191216 202OSCE 192241317 HP(http://self-medication.pha.nihon-u.ac.jp/)
32322 h3 13 121 1 OB 6 33331 4( ) 3 4 2 127 2212 13(103) 91 () 91718 15(114) ( ) 33332 1816511
856 3 2 15312 6 33334 67 211 1862 8 19 21257 214 34341 2003 5 4 8 16 3 3 3 2 4 31M2 20061459
34342 183 634 4 3 2 1679 112 6 34344 187 912 2 18 2 4 62 34345 44 2 11137 665 4 454 122 4 5123
2010 4 151 Bayesian2American College of Clinical Pharmacology 2006 Annual MeetingPharmacokinetic and Pharmacodynamic Modeling course3win BUGS PKBugs4NONMEM 9 11 4 12 319 1596 TDM/ 45 3 41411 123 9 3SPF 2SPF 1 167 11 4 ID 18 170356 56473 41412 634 183 34 26 3 H 14 C 32 P 18 117341 33449 42421 400MHz500MHz2FT- NMR(MS) GC-MSAUTO-MS ATR (IR) (LSM 12 NMRMSIR 20LSM NMRMSIR 18 3 MS 1999 1000 3 MS 1 1952425 http://www.apchem.metro-u.ac.jp/microganic/ )
54544 GIS GIS 500m GISWeb GIS GIS 109 15 3 ( ) ( ) 110 ( ) ( ) 111 ( ) ( ) () (4-8-24) JR2 A2 0 () 1730 () 1,000 (1) 24 self-medpha.nihon-u.ac.jp
45 181118 45 36 23 10 181029307 32 9 10
18923 345 1 61 3 3 30 15000 TEL 0258-82-2123 5 3 18 10 14 1 16 1945
2 19310, 1192 18317897.27% 97.50%2 87.07% 8 186 18 4 1F () 2F 3F (45) 2193 8 6 61 MR 14 565 6 4 computercbtcomputer based testingosceobjective structured clinical examination CBT CBT 43 OSCE4 4 6428.65m 2 611
65 543 19 83 2 5 6 1962 07.4.1 06.7.1 07.4.1 07.4.1 07.4.1 07.3.31 Zygosaccharomyces rouxii Saccharomyces cerevisiae Z. rouxii S. cerevisiae S. cerevisiae 2 Z. rouxii S. cerevisiae Z. rouxii Z. rouxii S. cerevisiae S. cerevisiae Z. rouxii S. cerevisiae cdna9098
30 20 3 31 3.5 193 3.5 () (1) (90) (2) 19111()9() 11 14() 11 16() 1119()1130() 10 11 274-8555 7-7-1 Tel 047-465-8480 () 115 () AB ( ) 6060 60100 2018()28() 25() 27() 28()18(),,,, 601114 301215 2 8 9 19 (1) (90) (2) 19111()() 1114() 1116() 1119()1130() 274-8555 7-7-1 Tel 047-465-8480 () 7/28 8/22
10 06. 11. 20. 10 11 8378 12 2 2 56 446 4 1510 332 5115 2 44 34 83 296,000 1010 1 4 2 10,000 83 h 55 12104 A 2 1034 4 43
13 101438 6 2014 332 14 OhMON CHOR (OB, OG) 10 Ave verum Corpus OG31 923 113 34199 OBOG 1957 113 198292 TEL & FAX 047-465-7362 E-mail; kimura@pha.nihon-u.ac.jp 10 18930 15140 5 4 571 1 75 2 62 3 83 4
63 84 69 2214 129 AED AED 1891114 2718
19 1962313301430 15001700 196118002000 701 19526 19331 399 42 62 19714530 160-0023 662 03-3344-5111 15 5 00100-4-557526 196 20() 274-8555 7-7-1 E-y-ogawa@pha.nihon-u.ac.jp E-kusamak@pha.nihon-u.ac.jp E-sudaatsu@pha.nihon-u.ac.jp 047-465-3740047-465-3794 FAX047-465-3794 1992214 4-8-24 1,000 2
18 2 18114() 11:001200 2131 4 9 10 13 IT14 15 21IT 25 301 1824 1 6 14 ( ) 1) 45 1015 10,5008,819 2) 282891114 27(1AED) () 1) 3 513()10001200 6 1204 (USB)204 38 (12) OTC (26) (40) 2) 520() 561 (56,100) 484 ( 242,000) 3) 9 1026()9 (28) 4) 1336130,000220,000310,000 (500) IT (IT) 1) HP () 1) 11 () 1) 17 50081 12,000 2) NL PRO() 210,000 3) 731 95 4) 1 () 1) 7191800 2) 249 826 () 1) 93015140
() () 1) 19 10,000(8,000) 2) 300,000 (2,000 ) 1) 91026 2) 1092 10,000 410 8 3) 11292 ( ) 4) 745 181() ()1 () 1) 18 18(19325) 2) 18 17 4 () 1) 0.5 () 1) 19922() 1) 2) 1 193231014 15 24361 2 3) 19581120081150 4) 19316()18204 18 17 325 18 (M2 ) (4) 211 1220 19 (35) 14 19
MR, OTC CRO DMF OEM OTCOEM CPhI 41820 1 E-mail: s_harada@ma.kitanet.ne.jp 189119228 2000, 62, 85, 17 4000, 2 10000, ID ID ID 10 10IDID ID 10,, 71 a,,,,, h 29 20000,,,,,,, j,,,,, 16
1119 192330 512 7 18 19 3,000 38 15 1915 TEL 0332678056 771 274-8555 FAX 0474651478 e-mail: alumni@pha.nihon-u.ac.jp 00140053798